2D/1D MoS2 /TiO2 Heterostructure Photocatalyst with a Switchable CO2 Reduction Product

Regulating the transfer pathway of charge carriers in heterostructure photocatalysts is of great importance for selective CO₂ photoreduction. Herein, the charge transfer pathway and in turn the redox potential succeeded to regulate in 2D MoS₂ /1D TiO₂ heterostructure by varying the light wavelength range. Several in situ measurements and experiments confirm that charge transfer follows either an S-scheme mechanism under simulated solar irradiation or a heterojunction approach under visible light illumination, elucidating the switchable property of the MoS₂ /TiO₂ heterostructure. Replacing the simulated sunlight irradiation with the visible light illumination switches the photocatalytic CO₂ reduction product from CO to CH_4. ¹³ CO₂ isotope labeling confirms that CO₂ is the source of carbon for CH₄ and CO products. The photoelectrochemical H₂ generation further supports the switching property of MoS₂ /TiO₂ . Unlike previous studies, density functional theory calculations are used to investigate the band structure of Van der Waals MoS₂ /TiO₂ S scheme after contact, allowing to propose accurate charge transfer pathways, in which the theoretical results are well matched with the experimental results. This work opens the opportunity to develop photocatalysts with switchable charge transport and tunable redox potential for selective artificial photosynthesis.

One-Step Hydrothermal Synthesis of Anatase TiO2 Nanotubes for Efficient Photocatalytic CO2 Reduction

The hydrothermal dissolution-recrystallization process is a key step in the crystal structure of titania-based nanotubes and their composition. This work systematically studies the hydrothermal conditions for directly synthesizing anatase TiO₂ nanotubes (ATNTs), which have not been deeply discussed elsewhere. It has been well-known that ATNTs can be synthesized by the calcination of titanate nanotubes. Herein, we found the ATNTs can be directly synthesized by optimizing the reaction temperature and time rather than calcination of titanate nanotubes, where at each temperature, there is a range of reaction times in which ATNTs can be prepared. The effect of NaOH/TiO₂ ratio and starting materials was explored, and it was found that ATNTs can be prepared only if the precursor is anatase TiO₂, using rutile TiO₂ leads to forming titanate nanotubes. As a result, ATNTs produced directly without calcination have excellent photocatalytic CO₂ reduction than titanate nanotubes and ATNTs prepared by titanate calcination.

Rational design of 2D TiO2-MoO3 Step-scheme heterostructure for boosted photocatalytic overall water splitting

Designing of step-scheme (S-scheme) heterostructure photocatalyst is a promising strategy for the high utilization of photogenerated charge carriers. Herein, a novel S-scheme two-dimensional (2D) TiO2-MoO3 heterojunction photocatalyst is fabricated by...

Design and synthesis of coumarin-triazole hybrids: biocompatible anti-diabetic agents, in silico molecular docking and ADME screening

The current study demonstrates the synthesis of coumarin-triazole hybrids 8 (a-e) in four steps starting from substituted salicylaldehyde 1 (a-e), and diethyl malonate 2. The spectroscopic studies provide the structure proofs of the new compounds, and the molecular structure of an intermediate 3a by crystallographic studies. The crystal structure analysis revealed the C–H...O, C–H... π, C–O...π and π...π molecular interactions. Further, the intermolecular interactions were quantified using Hirshfeld surface analysis and the DFT method B3LYP functional with 6–311++ G (d,p) basis set was employed to optimize the molecular geometry. The synthesized new coumarin-triazole hybrids, 8 (a–e) were screened for their α-amylase inhibitory potentials, and the results suggest that amongst the series, compounds 8c, and 8e show the promising inhibition of the enzyme, and might act as lead molecules for anti-diabetic activities. To understand the mode of action in silico molecular docking and ADME screening were performed.

Synthesis of novel spirobibenzopyrans as potent anticancer leads inducing apoptosis in HeLa cells

Spirobibenzopyrans are an unexplored class of therapeutics. We report the anticancer activity of novel spirobibenzopyrans, synthesized by a one-pot reaction and extensively characterized. Structure of one of the spirobibenzopyran has been determined by the single crystal XRD technique. The in vitro anticancer activity of these derivatives across the NCI 60-cell line panel was evaluated and for the first time their mechanism of action against HeLa cells was probed via cell morphology analysis and cell cycle analysis. They were determined to be apoptosis inducers with cell cycle arrest in G₀/G₁ and S phase suggesting CDK-4 protein inhibition and the inhibition of DNA replication. The DNA inhibition was studied and confirmed using the alkaline comet assay for the compound CHX-4MO-SAL showing S phase inhibition. Further, conformity with the in silico Lipinski's score signify the potential of spirobibenzopyrans as anticancer leads.

SiCl4mediated one-pot synthesis of novel spirobibenzopyrans as potent anticancer agents

This study is the first report on the anticancer activity of spirobibenzopyrans, an unexplored class of therapeutic agents.